UK MHRA Full Steam Ahead On Transformation Plan But Medtech Regulation Still Held Up

UK regulatory agency’s One Agency approach on cusp of going live

Teething troubles including staffing issues and a hold-up in the progress of the post-Brexit medical devices statutory instruments have beset the UK MHRA as it transforms to a new lifecycle-based regulatory agency that puts primacy on patient safety. But there is much to celebrate, says chief executive June Raine.

Shutterstock

The “people” aspects of the UK Medicines and Healthcare products Regulatory Agency’s (MHRA) transformation remain a key priority, the agency’s 21 June board meeting held in public heard. Recruitment to new agency roles has taken longer than anticipated, but with over 90% of them now filled, the new MHRA structure officially came into operation on the designation date of 1 June, the agency’s chief executive, June Raine, said.

“We are in business,” she said, adding that the live launch of the new “One Agency” will take place in...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from United Kingdom

More from Europe